FDA approves a risk evaluation to ensure the safe use of Erythropoiesi
- This topic has 0 replies, 1 voice, and was last updated 14 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
FDA approves a risk evaluation and mitigation strategy (REMS) to ensure the safe use of Erythropoiesis-Stimulating Agents (ESAs)”
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm200847.htm
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.